av/cadila-healthcare--big.svg

COM:ZYDUSLIFE

Zydus Lifesciences Ltd.

  • Stock

Last Close

944.05

22/11 10:00

Market Cap

1.17T

Beta: -

Volume Today

295.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
72.24B
-
86.51B
19.76%
98.38B
13.71%
94.30B
4.15%
115.99B
23.01%
127.48B
9.91%
127.48B
0%
148.22B
16.26%
148.28B
0.04%
148.28B
0%
190.22B
28.28%
cost of revenue
28.21B
-
33.10B
17.32%
34.60B
4.54%
36.36B
5.10%
43.43B
19.44%
49.50B
13.98%
49.50B
0%
54.80B
10.71%
58.19B
6.18%
58.19B
0%
62.28B
7.03%
gross profit
44.03B
-
53.42B
21.32%
63.78B
19.40%
57.93B
9.16%
72.56B
25.26%
77.98B
7.47%
77.98B
0%
93.42B
19.79%
90.09B
3.56%
90.09B
0%
127.93B
42.01%
selling and marketing expenses
9.02B
-
9.60B
6.42%
10.20B
6.25%
8.30B
18.68%
10.14B
22.27%
10.35B
2.06%
10.35B
0%
13.88B
34.07%
13.73B
1.07%
13.73B
0%
general and administrative expenses
1.79B
-
1.77B
1.28%
2.32B
31.09%
2.46B
5.91%
2.75B
11.81%
3.40B
23.67%
3.40B
0%
4.72B
39.02%
4.28B
9.32%
4.28B
0%
selling general and administrative expenses
10.82B
-
11.37B
5.14%
12.52B
10.11%
10.75B
14.13%
12.89B
19.88%
13.75B
6.66%
13.75B
0%
18.60B
35.29%
18.01B
3.17%
18.01B
0%
35.69B
98.11%
research and development expenses
574M
-
1.09B
89.90%
1.39B
27.34%
1.44B
3.89%
1.69B
17.13%
1.08B
36.12%
1.08B
0%
1.18B
9.73%
1.15B
3.21%
1.15B
0%
13.10B
1,042.76%
other expenses
28M
-
92M
228.57%
131M
42.39%
80M
38.93%
46M
42.50%
81M
76.09%
81M
0%
51M
37.04%
31M
39.22%
46.16B
148,803.23%
2.84B
93.85%
cost and expenses
62.13B
-
71.62B
15.27%
77.53B
8.24%
78.94B
1.81%
92.99B
17.81%
104.25B
12.11%
104.25B
0%
121.95B
16.97%
123.51B
1.28%
123.51B
0%
144.82B
17.26%
operating expenses
33.92B
-
38.53B
13.57%
42.93B
11.43%
42.57B
0.83%
49.56B
16.42%
54.76B
10.48%
54.76B
0%
67.15B
22.64%
65.32B
2.73%
65.32B
0%
82.54B
26.36%
interest expense
1.10B
-
555M
49.59%
410M
26.13%
568M
38.54%
1.05B
84.33%
1.91B
81.95%
1.91B
0%
1.60B
15.80%
1.14B
28.68%
1.14B
0%
812M
29.02%
ebitda
12.81B
-
18.03B
40.75%
24.62B
36.55%
19.89B
19.22%
29.27B
47.19%
30.46B
4.05%
30.46B
0%
33.99B
11.62%
34.28B
0.84%
34.28B
0%
56.68B
65.35%
operating income
10.11B
-
14.89B
47.34%
20.85B
40.02%
15.36B
26.32%
23.00B
49.75%
23.93B
4.02%
23.23B
2.91%
27.36B
17.77%
24.74B
9.56%
26.92B
8.81%
49.04B
82.17%
depreciation and amortization
2.01B
-
2.87B
42.79%
3.02B
5.19%
3.75B
24.09%
5.41B
44.13%
5.99B
10.75%
5.99B
0%
7.25B
21.08%
7.36B
1.56%
7.36B
0%
167.90K
100.00%
total other income expenses net
-683M
-
-434M
36.46%
390M
189.86%
759M
94.62%
306M
59.68%
364M
18.95%
592M
62.64%
-2.89B
588.18%
4.10B
241.94%
1.46B
64.41%
-954M
165.34%
income before tax
9.42B
-
14.46B
53.42%
21.24B
46.92%
16.12B
24.10%
23.31B
44.60%
23.82B
2.20%
23.82B
0%
22.85B
4.08%
28.38B
24.22%
28.38B
0%
48.09B
69.44%
income tax expense
1.06B
-
2.59B
144.72%
5.71B
120.16%
1.29B
77.43%
5.64B
337.86%
5.30B
6.04%
5.30B
0%
1.47B
72.24%
5.12B
247.62%
5.12B
0%
9.78B
91.03%
net income
8.04B
-
11.48B
42.92%
15.23B
32.57%
14.88B
2.29%
17.76B
19.37%
18.49B
4.11%
18.49B
0%
21.34B
15.40%
44.87B
110.32%
19.65B
56.21%
38.37B
95.25%
weighted average shs out
1.02B
-
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.01B
1.13%
weighted average shs out dil
1.02B
-
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.02B
0%
1.01B
1.13%
eps
7.85
-
11.24
43.18%
19.19
70.73%
14.53
24.28%
17.35
19.41%
18.06
4.09%
18.06
0%
20.84
15.39%
43.83
110.32%
22.72
48.16%
37.90
66.81%
epsdiluted
7.85
-
11.24
43.18%
19.19
70.73%
14.53
24.28%
17.35
19.41%
18.06
4.09%
18.06
0%
20.84
15.39%
43.83
110.32%
22.72
48.16%
37.90
66.81%

All numbers in (except ratios and percentages)